Published in Eur J Clin Microbiol on February 01, 1983
Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood. J Clin Microbiol (1983) 3.79
Clinical evaluation of the lysis-centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system. J Clin Microbiol (1984) 1.97
New biphasic culture system for isolation of mycobacteria from blood of patients with acquired immune deficiency syndrome. J Clin Microbiol (1984) 1.56
Comparison of the lysis-centrifugation and agitated biphasic blood culture systems for detection of fungemia. J Clin Microbiol (1991) 1.38
Effect of storage of the du Pont lysis-centrifugation system on recovery of bacteria and fungi in a prospective clinical trial. J Clin Microbiol (1984) 1.24
Comparison of Du Pont Isolator and Roche Septi-Chek for detection of fungemia. J Clin Microbiol (1987) 1.19
Impact of the BACTEC NR system in detecting Candida fungemia. J Clin Microbiol (1990) 0.91
Effect of hydrogen peroxide on growth of Candida, Cryptococcus, and other yeasts in simulated blood culture bottles. J Clin Microbiol (1991) 0.83
Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
Comparison of two commercially available media for detection of bacteremia. Appl Microbiol (1971) 11.61
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol (1983) 10.49
Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother (1993) 8.36
Identification of mycobacteria from culture by using the Gen-Probe Rapid Diagnostic System for Mycobacterium avium complex and Mycobacterium tuberculosis complex. J Clin Microbiol (1988) 7.74
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother (1995) 7.44
Comparison of in vitro activity of cephalexin, cephradine, and cefaclor. Antimicrob Agents Chemother (1977) 7.14
Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol (1983) 7.02
Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc (1975) 7.01
Blood cultures: issues and controversies. Rev Infect Dis (1986) 6.95
Radiometric method for detection of bacteremia. Appl Microbiol (1971) 6.77
Evaluation of radiometric system for detecting bacteremia. Appl Microbiol (1973) 6.26
Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol (1980) 5.99
Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol (1996) 5.80
Effects of atmosphere of incubation and of routine subcultures on detection of bacteremia in vacuum blood culture bottles. J Clin Microbiol (1975) 5.78
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol (1983) 5.77
Multi-laboratory evaluation of an automated microbial detection/identification system. J Clin Microbiol (1978) 5.74
New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob Agents Chemother (1989) 5.49
Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27
Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol (2010) 5.25
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology (1997) 5.22
Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J Clin Microbiol (1986) 5.19
Evaluation of the Repliscan system for identification of Enterobacteriaceae. J Clin Microbiol (1978) 5.07
Genetic characterization of clones of the bacterium Listeria monocytogenes causing epidemic disease. Proc Natl Acad Sci U S A (1989) 5.00
Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother (1998) 4.93
Blood cultures: principles and techniques. Mayo Clin Proc (1975) 4.87
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Effect of volume of blood cultured on detection of bacteremia. J Clin Microbiol (1976) 4.75
Identification of clinical isolates of mycobacteria with gas-liquid chromatography alone. J Clin Microbiol (1979) 4.67
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
Comparison of two liquid blood culture media containing sodium polyanethole sulfonate: tryptic soy and Columbia. Appl Microbiol (1974) 4.52
Detection of bacteremia with liquid media containing sodium polyanetholsulfonate. Appl Microbiol (1974) 4.41
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother (1996) 4.24
Clinical laboratory evaluation of automated microbial detection/identification system in analysis of clinical urine specimens. J Clin Microbiol (1979) 4.12
Medical student selection--time for change: discussion paper. J R Soc Med (1989) 4.08
Evaluation of the necessity for routine terminal subcultures of previously negative blood cultures. J Clin Microbiol (1980) 4.08
Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Appl Microbiol (1974) 4.06
The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis (1983) 4.05
Detection of fungi in blood cultures. J Clin Microbiol (1975) 4.05
Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood. J Clin Microbiol (1983) 3.79
The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc (1999) 3.79
Evaluation of two commercially available media for detection of bacteremia. Appl Microbiol (1972) 3.77
Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol (1979) 3.77
Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol (1997) 3.54
Recovery of yeast from vented blood culture bottles. J Clin Microbiol (1975) 3.42
Laboratory approaches to the identification of Enterobacteriaceae. Hum Pathol (1976) 3.30
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis (1978) 3.29
Molecular probes for diagnosis of fungal infections. J Clin Microbiol (1995) 3.29
Evaluation of a biphasic medium for blood cultures. J Clin Microbiol (1979) 3.23
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.06
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol (1989) 2.96
Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol (1999) 2.94
Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am (1977) 2.94
Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis (1987) 2.93
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87
The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother (1999) 2.87
Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85
Evaluation of blood culture media supplemented with sucrose or with cysteine. J Clin Microbiol (1975) 2.81
The in vitro spectrum of the cephalosporins. Mayo Clin Proc (1976) 2.72
Microbiological study of streptococcal bacteremia. Appl Microbiol (1973) 2.70
Matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative to 16S rRNA gene sequencing for identification of difficult-to-identify bacterial strains. J Clin Microbiol (2010) 2.69
Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol (1993) 2.66
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii. Antimicrob Agents Chemother (1984) 2.65
Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates. Antimicrob Agents Chemother (1974) 2.65
Coryneform bacterial endocarditis: difficulties in diagnosis and treatment, presentation of three cases, and review of literature. Mayo Clin Proc (1977) 2.63
Evaluation of the modified Micro-ID system for identification of Enterobacteriaceae. J Clin Microbiol (1979) 2.61
Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51
Rapid urea broth test for yeasts. J Clin Microbiol (1978) 2.50
Vaginal flora in asymptomatic women. Mayo Clin Proc (1976) 2.49
Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin Microbiol Rev (1988) 2.48
Evaluation of a routine anaerobic subculture of blood cultures for detection of anaerobic bacteremia. J Clin Microbiol (1978) 2.44
Comparison of recovery of organisms from blood cultures diluted 10% (volume/volume) and 20% (volume/volume). J Clin Microbiol (1982) 2.42
Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users. J Clin Microbiol (1995) 2.41
Antimicrobial susceptibility of enterobacteriaceae and nonfermenting gram-negative bacilli. Mayo Clin Proc (1969) 2.41
Polymicrobial bacteremia. Ann Intern Med (1970) 2.40
The antimicrobial removal device. A microbiological and clinical evaluation. Am J Clin Pathol (1982) 2.40
Comparison of PCR-based DNA fingerprinting techniques for the identification of Listeria species and their use for atypical Listeria isolates. Int J Syst Bacteriol (1998) 2.40
Mycobacteremia and the new blood culture systems. Ann Intern Med (1983) 2.39
Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis (1979) 2.37
Bacteroides bacteremia. Minn Med (1970) 2.36
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med (1999) 2.35
Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology (1994) 2.35
Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis (1993) 2.35
Comparison of direct and standardized antimicrobial susceptibility testing of positive blood cultures. Antimicrob Agents Chemother (1976) 2.30
Comparison of four methods for determining nitrate utilization by cryptococci. J Clin Microbiol (1975) 2.29
Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother (2000) 2.27
Controlled clinical evaluation of BACTEC Plus Aerobic/F and BacT/Alert Aerobic FAN bottles for detection of bloodstream infections. J Clin Microbiol (1995) 2.25
Optimal time for routine early subculture of blood cultures. J Clin Microbiol (1980) 2.24
Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. J Clin Microbiol (1996) 2.23
Nocardiosis. A review of 25 cases occurring during 24 months. Mayo Clin Proc (1975) 2.19